Effects of Sanoshashinto on left ventricular hypertrophy and gut microbiota in spontaneously hypertensive rats

被引：0
|
作者：
Jianbo Wu
Souichi Nakashima
Seikou Nakamura
Hisashi Matsuda
机构：
[1] Kyoto Pharmaceutical University,Department of Pharmacognosy
来源：
Journal of Natural Medicines | 2020年 / 74卷
关键词：
Sanoshashinto; Baicalin; Berberine; K; VDCC; Gut microbiota;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In our previous study, we found that the methanolic extract of Sanoshashinto (三黄瀉心湯) (SHXXTM) exhibited significant vasorelaxant effects in vitro and antihypertensive effects in vivo, and baicalin and berberine were the main antihypertensive constituents in SHXXTM. We also speculated that the baicalin–berberine (BB) combination produced vasorelaxant effects by activating the NO/cGMP pathway, and the BKCa channel and the DAG/PKC/CPI-17 pathway were involved. In this study, we examined the vasorelaxant effects using helical strips of rat aorta pretreated with different activators or inhibitors. The results suggested that the KATP channel and the voltage-dependent Ca2+ channel (VDCC) were also involved in the vasorelaxant effects. Furthermore, we found that SHXXTM and the BB combination reduced left ventricular hypertrophy and altered gut microbiota. Together, the results indicated that Sanoshashinto might have comprehensive effects on ameliorating hypertension.
引用
收藏
页码：482 / 486
页数：4
相关论文
共 105 条
  • [1] Motoo Y(2011)Traditional Japanese medicine, Kampo: its history and current status Chin J Integr Med 17 85-87
  • [2] Seki T(2020)Antihypertensive constituents in Sanoshashinto J Nat Med. 17 760-770
  • [3] Tsutani K(2010)Baicalin, a flavonoid from Phytomedicine 399 187-196
  • [4] Wu JB(2000) Georgi, activates large-conductance Ca Eur J Pharmacol 130 198-203
  • [5] Nakashima S(2018)-activated K Pharmacol Res 144 390-408
  • [6] Shigyo M(2018) channels via cyclic nucleotide-dependent protein kinases in mesenteric artery Pharmacol Res 65 1331-1340
  • [7] Yamasaki M(2015)Vasorelaxant and antiproliferative effects of berberine Hypertension 68 476-532
  • [8] Ikuno S(2016)Gut microbiota in kidney disease and hypertension Pharmacol Rev 44 187-196
  • [9] Morikawa A(2018)Gut microbiota, hypertension and chronic kidney disease: recent advances ScienceAsia 26 1-8
  • [10] Takegami S(2016)Gut dysbiosis is linked to hypertension Curr Opin Nephrol Hypertens 11 1982-1996
12345678910